SOUTH SAN FRANCISCO, Calif., Jan. 9, 2026 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (“Rigel”) (Nasdaq: RIGL)...
PR Newswire
Participation underscores growing excitement around company’s momentum and potential in precision oncology GENEVA, AMSTERDAM and...
BOSTON, Jan. 9, 2026 /PRNewswire/ — Averna Therapeutics, Inc., a biotechnology company developing novel genomic...
Led by Nantahala Capital, Stonepine Capital Management, Pointillist Partners, LLC, and The Red Hook Fund,...
NEW YORK, Jan. 9, 2026 /PRNewswire/ — GRIN Therapeutics, Inc., a leader in the development...
PITTSBURGH, Jan. 9, 2026 /PRNewswire/ — Avista Therapeutics, a preclinical gene therapy company built on...
This marks CytoReason’s fifth commercial deal of 2025 and builds on its track record with...
MONTREAL, Jan. 9, 2026 /PRNewswire/ – Find Therapeutics Inc., a biopharmaceutical company focused on the...
CAMBRIDGE, Mass., Jan. 9, 2026 /PRNewswire/ — Nona Biosciences (“Nona”), a global biotechnology company advancing...
— BRINSUPRI® (brensocatib) Unaudited Total Revenues of Approximately $144.6 Million for First Full Quarter of Launch; Approximately...